Follow the 에이비프로바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Industrials sector, 에이비프로바이오 has published 53 public disclosures. Market capitalisation: €19.3bn. The latest transaction was reported on 27 May 2026 (Other). Among the most active insiders: 상상인저축은행. All data is openly available.
53
Insider Decl.
n/a
Thresholds
€2m
34 ops.
Buy Volume
n/a
2 ops.
Sell Volume
10Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Established in the industrial sector, 에이비프로바이오 is a company listed on the XKRX market. It specializes in the development of biopharmaceutical products.